226 related articles for article (PubMed ID: 15161563)
1. Genetic alterations in prostate cancer.
Chin JL; Reiter RE
Curr Urol Rep; 2004 Jun; 5(3):157-65. PubMed ID: 15161563
[TBL] [Abstract][Full Text] [Related]
2. [New biomarkers for prostate cancer].
Suzuki H; Shimbo M; Ichikawa T
Nihon Rinsho; 2005 Feb; 63(2):351-9. PubMed ID: 15714991
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways to prostate cancer.
Gonzalgo ML; Isaacs WB
J Urol; 2003 Dec; 170(6 Pt 1):2444-52. PubMed ID: 14634448
[TBL] [Abstract][Full Text] [Related]
4. The complexity of prostate cancer: genomic alterations and heterogeneity.
Boyd LK; Mao X; Lu YJ
Nat Rev Urol; 2012 Nov; 9(11):652-64. PubMed ID: 23132303
[TBL] [Abstract][Full Text] [Related]
5. Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.
Habuchi T
Future Oncol; 2006 Apr; 2(2):233-45. PubMed ID: 16563092
[TBL] [Abstract][Full Text] [Related]
6. V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.
Nam RK; Toi A; Vesprini D; Ho M; Chu W; Harvie S; Sweet J; Trachtenberg J; Jewett MA; Narod SA
Urology; 2001 Jan; 57(1):199-204. PubMed ID: 11164181
[TBL] [Abstract][Full Text] [Related]
7. HPC2 variants and screen-detected prostate cancer.
Vesprini D; Nam RK; Trachtenberg J; Jewett MA; Tavtigian SV; Emami M; Ho M; Toi A; Narod SA
Am J Hum Genet; 2001 Apr; 68(4):912-7. PubMed ID: 11254449
[TBL] [Abstract][Full Text] [Related]
8. A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer.
Zahiri Z; Zahiri F
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1551-1557. PubMed ID: 32592348
[TBL] [Abstract][Full Text] [Related]
9. Role of prostate stem cell antigen in prostate cancer research.
Jalkut MW; Reiter RE
Curr Opin Urol; 2002 Sep; 12(5):401-6. PubMed ID: 12172427
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms and prostate cancer risk.
Gsur A; Feik E; Madersbacher S
World J Urol; 2004 Feb; 21(6):414-23. PubMed ID: 14648103
[TBL] [Abstract][Full Text] [Related]
11. Molecular advances in prostate cancer.
Dong JT; Isaacs WB; Isaacs JT
Curr Opin Oncol; 1997 Jan; 9(1):101-7. PubMed ID: 9090501
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
13. [Androgen receptor variants in prostate cancer].
Schreyer E; Barthélémy P; Cottard F; Ould Madi-Berthélémy P; Schaff-Wendling F; Kurtz JE; Céraline J
Med Sci (Paris); 2017; 33(8-9):758-764. PubMed ID: 28945566
[TBL] [Abstract][Full Text] [Related]
14. Genomic approaches to outcome prediction in prostate cancer.
Febbo PG
Cancer; 2009 Jul; 115(13 Suppl):3046-57. PubMed ID: 19544546
[TBL] [Abstract][Full Text] [Related]
15. Associations of polymorphisms in HPC2/ELAC2 and SRD5A2 genes with benign prostate hyperplasia in Turkish men.
Izmirli M; Arikan B; Bayazit Y; Alptekin D
Asian Pac J Cancer Prev; 2011; 12(3):731-3. PubMed ID: 21627373
[TBL] [Abstract][Full Text] [Related]
16. CYP17 gene promoter allelic variant is not associated with prostate cancer.
Lin CC; Wu HC; Chen WC; Chen HY; Tsai FJ
Urol Oncol; 2003; 21(4):262-5. PubMed ID: 12954495
[TBL] [Abstract][Full Text] [Related]
17. Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications.
Hahn NM; Kelley MR; Klaunig JE; Koch MO; Li L; Sweeney CJ
Future Oncol; 2007 Dec; 3(6):665-82. PubMed ID: 18041919
[TBL] [Abstract][Full Text] [Related]
18. PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
Li L; Zhang D; Zhang L; Zhu G; Sun Y; Wu K; Wang X; He D
Mol Carcinog; 2009 May; 48(5):432-40. PubMed ID: 18800346
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism of glutathion-S-transferase genes in patients with prostatic cancer].
Davydova NA; Dmitrieva AI; Selivanov SP; Tkachenko SB; Kovalik TA; Kolomiets SA; Sevast'ianova NV; Novitskiĭ VV
Urologiia; 2008; (2):26-9. PubMed ID: 18572765
[TBL] [Abstract][Full Text] [Related]
20. MnSOD gene polymorphism association with steroid-dependent cancer.
Bica CG; de Moura da Silva LL; Toscani NV; da Cruz IB; Sá G; Graudenz MS; Zettler CG
Pathol Oncol Res; 2009 Mar; 15(1):19-24. PubMed ID: 18553161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
